Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05190666 · ClinicalTrials.gov registry record · NA
Healthy Living After Knee Replacement
A NA study of Overweight and Obesity and Arthroplasty, sponsored by University of South Carolina.
- Active
- Registry status
- NA
- Development phase
- 181
- Enrollment target
- 1
- Study location
NCT05190666: Active NA study of Overweight and Obesity and Arthroplasty, sponsored by University of South Carolina.
NCT05190666 is a NA study of Overweight and Obesity and Arthroplasty that is active but no longer recruiting, run by University of South Carolina. The registered enrollment target is 181 participants, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05190666, a NA study of Overweight and Obesity and Arthroplasty, is active but no longer recruiting, sponsored by University of South Carolina.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 181 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine if a weight loss program designed for adults after knee replacement improves weight loss, physical activity, pain, and function, as well as if the program is cost effective, as compared to a chronic disease self-management program.
Primary Outcome
kg
Conditions Studied
Interventions
- BEHAVIORAL PACE Weight Loss program
- BEHAVIORAL Chronic Disease Self-Management
Study Locations (1)
South Carolina
- University of South Carolina - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2022-01-04 |
| Est. Completion | 2027-07-30 |
| Phase | NA |
What the registry record for NCT05190666 still lists
NCT05190666 is an interventional study that assigns participants to a tested intervention. The registered 181 participants enrollment target is mid-sized for trials with a published cap, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (20% lower).
The record links to 2 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which PACE Weight Loss program is the first listed.
NCT05190666 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT05190666 about?
NCT05190666 is a clinical study titled "Healthy Living After Knee Replacement". The purpose of this study is to examine if a weight loss program designed for adults after knee replacement improves weight loss, physical activity, pain, and function, as well as if the program is cost effective, as compared to a chronic disease self-management program.
What is the current status of trial NCT05190666?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 181 participants. The study started on 2022-01-04. Estimated completion is 2027-07-30.
What conditions does trial NCT05190666 study?
This clinical trial studies the following conditions: Overweight and Obesity, Arthroplasty.
What interventions are being tested in trial NCT05190666?
The interventions under investigation include: PACE Weight Loss program (BEHAVIORAL), Chronic Disease Self-Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT05190666?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05190666 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05190666's enrollment target sits among peer trials
181 34th of 115 higher than 82 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04578392 · 181 participants · NA
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)
- NCT05597891 · 181 participants · NA
Endovascular Engineering ENGULF Study
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI